TickerTalks
Browse all tickers →
TickerTalks›$SLP
SLSLP

Simulations Plus, Inc.

$SLP·$371M·Software - Application·Technology
$18.36+0.2%YTD-0.3%1Y+41.0%
Mentions · last 7 days
2026-07-28: 13 posts2026-07-29: 4 posts2026-07-30: 4 posts2026-07-31: 1 posts2026-08-01: 4 posts2026-08-02: 3 posts2026-08-03: 19 posts48+13%
Price updated 8m ago·X counts updated 18h ago
SLSLP
$SLPSimulations Plus, Inc.
$18.36+0.25%48 posts+13%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Top X posts

Today's AI verdict on what's driving $SLP, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Hinges on a big eventEvent coming upAI verdict · as of 2026-08-04

A known event soon (earnings, a ruling, etc.) will likely decide the next move.

Simulations Plus signed a $0.001-consideration merger agreement (SP Evolution Holdings) — merger-arb setup with fair-price investigations underway.

Simulations Plus is a pharmaceutical simulation-and-modeling software company (drug discovery workflow tools) that just signed a definitive merger agreement with SP Evolution Holdings on June 15. Multiple law firms are investigating the fairness of the sale price.

  • The June 15 merger agreement is the story-defining event: definitive Agreement and Plan of Merger with SP Evolution Holdings — a take-private converting SLP to a merger-arb setup with terminal-value clarity.
  • Multi-firm price/process investigations are standard for announced deals: Kahn Swick & Foti, Robbins LLP, and others investigating price/process — reflexive M&A class-action probing, meaningful because it could delay close or force a consideration bump.
  • Q2 (fiscal Feb 2026) was solid: revenue grew 8% YoY to $24.3M with 66% GM and 23% OM plus $0.23 EPS — real operating execution for the standalone, and 62% TTM GM confirms pricing power that framed the bid.
  • The 6.2% FCF yield reflects the merger-arb spread: SLP trades at a discount to terminal-deal value — real spread mechanics until close, though a soft Q3 plus a fresh investigation could widen the spread.

Oct 29 Q3 fiscal is the tension breaker. Continued in-line execution plus concrete merger-close timeline compresses the arb-spread toward deal value; a soft Q3 or a further Kahn Swick update and the setup pauses with fair-value fundamentals (~$15) as the downside anchor with deal-timing uncertainty gaining airtime.

What to watch: Oct 29 Q3 print and merger timeline: watch for merger-close timing, any Kahn Swick investigation update, deal-consideration bump discussions, and standalone operational execution — the signals that resolve the merger-arb setup.

On the calendar: 2026-10-29 — Q3 (fiscal) earnings

sentiment ticker collision

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Mixed sentiment7 posts analyzed · as of 2026-08-03

The $SLP cashtag is split between Sylvania Platinum (a bearish note about a revenue/cost drop last week with a possible fair-value double if PGMs recover) and Axie Infinity's Smooth Love Potion ($SLP crypto). The AXS/SLP mentions are largely watchlist inclusion in Ronin gaming ecosystem lists and Binance outflow flow-of-funds posts; no strong directional consensus on either.

Read the AI verdict + X sentiment for $SLP

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Drug discovery software company using AI/ML for ADME/PK simulation (GastroPlus) and clinical pharmacology modeling.

Industry overviewAI analysisGenerated by AI from underlying data

Where Software - Application sits in its cycle right now — and what that implies for $SLP.

Software - Application · Technology

No material change from last week — platforms where agents expand contract value (ServiceNow, Snowflake) are re-rated upward, while tools where agents substitute human users (Adobe Creative..

What this means for $SLP

Neutral — Drug discovery software company using AI/ML for ADME/PK simulation (GastroPlus) and clinical pharmacology modeling; limited read-through from medical - healthcare information services macro dynamics to this specific revenue mix.

Top industry ETF

$IGViShares Expanded Tech-Software Sector ETF
-12.4%YTD
-12.2%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
-5.9How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
-47.4%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
-83.5%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
6.2%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
4.6Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
-49.3%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
62.0%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 9, 2026$0.30$0.23+29.0%
Q1 2026Apr 9, 2026$0.35$0.27+29.6%
Q4 2025Jan 8, 2026$0.13$0.18-27.8%
Q3 2025Dec 1, 2025$0.10$0.100.0%
Next earningsThu, Oct 29·consensus EPS $0.11

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$24.3M+8.3%66.5%23.2%$0.23$6.4M
Q1 FY26$18.4M-2.7%59.1%3.9%$0.03$3.3M
Q4 FY25$17.5M-6.5%56.4%3.8%$-0.03$5.3M
Q3 FY25$20.4M+9.8%64.0%-365%$-3.35$7.8M

Forward consensus

5-year forecast · up to 3 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$81.9M$81.4M – $82.3M$0.86$0.81 – $0.913
FY27$86.3M$85.8M – $86.7M$0.88$0.88 – $0.893
FY28$92.6M$92.1M – $93.0M$1.06$1.05 – $1.071
FY29$103.4M$102.8M – $103.9M$1.28$1.27 – $1.291
FY30$117.1M$116.4M – $117.7M$1.56$1.55 – $1.571

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.4×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.73%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+4.3%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+13.1%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 16.8M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.2% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β1.315-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellJul 6Dibella John Anthony IiChief Revenue Officer1.0K sh$18KSellJul 1Walter S WoltoszDirector4.2K sh$77KSellJun 16Jill Fiedler-kellyPresident7.3K sh$134KSellJun 15Jill Fiedler-kellyPresident1.1K sh$17KSellJun 3Dibella John Anthony IiChief Revenue Officer1.0K sh$17KSellJun 1Walter S WoltoszDirector15.0K sh$261KSellMay 11Jill Fiedler-kellyPresident1.0K sh$17KSellMay 4Walter S WoltoszDirector15.0K sh$227KSellMay 4Dibella John Anthony IiChief Revenue Officer1.0K sh$15KSellApr 15Dibella John Anthony IiChief Revenue Officer1.0K sh$13K
+ 8 other (4 exempts · 4 awards) in window

See when $SLP insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KPress release / Reg FDJul 98-K — Item 2.02: Earnings release · Item 7.01: Press release / Reg FD
AI summary

Simulations Plus (SLP) — 8-K (Items 2.02, 7.01) furnishing quarterly earnings results and a Reg FD investor presentation on July 9, 2026. Results provided as furnished exhibits. Material — quarterly earnings disclosure for the life-sciences simulation software company.

8-KMaterial agreementJun 178-K — Item 1.01: Material agreement · Item 5.02: Officer or director change
AI summary

California 001-32046 95-4595609 entered into a material merger agreement on 2026-06-17 for $0.001. Narrative: ment. Agreement and Plan of Merger On June 15, 2026, Simulations Plus, Inc., a California corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, SP Evolution HoldCo II, LLC, a Delaware limited liability company and an affiliat... California 001-32046 95-4595609 reported a compensatory arrangement or officer/director change: ment. Agreement and Plan of Merger On June 15, 2026, Simulations Plus, Inc., a California corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, SP Evolution HoldCo II, LLC, a Delaware limited liability company and an affiliate of Altaris, LLC (“ Parent ”) and SP Evolution BidCo II, LLC, a Delaware limited liability company .

8-KPress release / Reg FDJun 168-K — Item 7.01: Press release / Reg FD
AI summary

California 001-32046 95-4595609 furnished a Reg FD disclosure covering: announcing the execution of an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, SP Evolution HoldCo II, LLC, a Delaware limited liability company and an affiliate of Altaris, LLC (“Parent”), and SP Evolution BidCo II, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which Merger Sub will merge with and into.

8-KPress release / Reg FDApr 98-K — Item 2.02: Earnings release · Item 7.01: Press release / Reg FD
8-KOfficer or director changeFeb 188-K — Item 5.02: Officer or director change · Item 5.07: Shareholder vote
+ 7 other (2 10-Qs · 2 13Gs · 1 proxy · 1 PRER14A) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders?gurufocus.com·4d agoAre DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders?prnewswire.com·4d agoSimulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLPgurufocus.com·5d agoSimulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLPbusinesswire.com·5d agoSimulation Plus, Inc. Securities Fraud Investigation - Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Lawsnewsfilecorp.com·6d ago

More in Software - Application

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$MSTR$NOW$ZETA$UBER$CRM$SNOW$ADBE$SOUN
Voices on X · top 4 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport